Growth Metrics

NovoCure (NVCR) Change in Acquisitions & Divestments (2016 - 2026)

NovoCure's Change in Acquisitions & Divestments history spans 13 years, with the latest figure at $110.0 million for Q1 2026.

  • On a quarterly basis, Change in Acquisitions & Divestments fell 8.33% to $110.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.3 billion, a 99.22% increase, with the full-year FY2025 number at $1.3 billion, up 65.17% from a year prior.
  • Change in Acquisitions & Divestments hit $110.0 million in Q1 2026 for NovoCure, down from $560.0 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for NVCR hit a ceiling of $560.0 million in Q4 2025 and a floor of $104.5 million in Q4 2022.
  • Historically, Change in Acquisitions & Divestments has averaged $268.7 million across 5 years, with a median of $275.5 million in 2023.
  • Biggest five-year swings in Change in Acquisitions & Divestments: tumbled 54.11% in 2022 and later surged 229.41% in 2025.
  • Tracing NVCR's Change in Acquisitions & Divestments over 5 years: stood at $104.5 million in 2022, then skyrocketed by 185.62% to $298.5 million in 2023, then crashed by 43.06% to $170.0 million in 2024, then surged by 229.41% to $560.0 million in 2025, then plummeted by 80.36% to $110.0 million in 2026.
  • Business Quant data shows Change in Acquisitions & Divestments for NVCR at $110.0 million in Q1 2026, $560.0 million in Q4 2025, and $185.0 million in Q3 2025.